ANIK  valuation analysis

Basics
Name: Anika Therapeutics, Inc
Description: Anika Therapeutics, Inc., together with its subsidiaries, operates as a joint preservation company that in the United States, Europe, and internationally. (more)
Industry: Biotechnology
Last 10Q10Qs are quarterly reports which contain a company's financial figures. We use these to calculate the FFER.: May 06, 2021
Market cap: $585.85M (1359th)
Sales(TTM): $129.35M (1387th)
Earnings(TTM): -$26.94M (1193rd)

Value
FFER: 0.45*
Actual price: $40.78
* Earnings were reported Jul 28, 2021 but we do not have the financials for this quarter. This is likely because the company has not yet released them. However, it might also be a problem with data quality. Regardless, you should take the FFER above with a grain of salt until we get updated financials.

Prices as of EOD 2021-07-15
Price & Estimates
Sales & Earnings history (TTM)
Notable
  • Anika Therapeutics, Inc's earnings decreased from $28.48M to -$26.94M in the last year.
  • Anika Therapeutics, Inc's operating income decreased from $29.48M to -$18.75M in the last year.
Earnings / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Sales / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Book / MarketCap
Anika Therapeutics, Inc
"Biotechnology" industry
Equity / Assets
Anika Therapeutics, Inc
"Biotechnology" industry